These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21900096)

  • 1. New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop.
    Schwartz Longacre L; Kloner RA; Arai AE; Baines CP; Bolli R; Braunwald E; Downey J; Gibbons RJ; Gottlieb RA; Heusch G; Jennings RB; Lefer DJ; Mentzer RM; Murphy E; Ovize M; Ping P; Przyklenk K; Sack MN; Vander Heide RS; Vinten-Johansen J; Yellon DM;
    Circulation; 2011 Sep; 124(10):1172-9. PubMed ID: 21900096
    [No Abstract]   [Full Text] [Related]  

  • 2. State of the science of cardioprotection: Challenges and opportunities--proceedings of the 2010 NHLBI Workshop on Cardioprotection.
    Kloner RA; Schwartz Longacre L
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):223-32. PubMed ID: 21821520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: fish oil and cardiac function.
    Nestel PJ
    World Rev Nutr Diet; 1991; 66():268-77. PubMed ID: 2053344
    [No Abstract]   [Full Text] [Related]  

  • 4. The National Cooperative Trial on Multifactorial Prevention of First Heart Attacks and Coronary Mortality in Free-Living, High-Risk, Middle-Aged American Men, Also Known as JUMBO: A Short Story.
    Blackburn H
    Am J Epidemiol; 2020 Jun; 189(6):491-498. PubMed ID: 31712828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CAESAR: one step beyond in the construction of a translational bridge for cardioprotection.
    Fernández-Jiménez R; Ibanez B
    Circ Res; 2015 Feb; 116(4):554-6. PubMed ID: 25677511
    [No Abstract]   [Full Text] [Related]  

  • 6. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.
    Hausenloy DJ; Baxter G; Bell R; Bøtker HE; Davidson SM; Downey J; Heusch G; Kitakaze M; Lecour S; Mentzer R; Mocanu MM; Ovize M; Schulz R; Shannon R; Walker M; Walkinshaw G; Yellon DM
    Basic Res Cardiol; 2010 Nov; 105(6):677-86. PubMed ID: 20865418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New horizons in cardioprotection. Proceedings of a National Heart, Lung, and Blood Institute (NHLBI) workshop. September 21-21, 2010. Rockville, Maryland, USA.
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):222-387. PubMed ID: 22329033
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardioprotection Beyond Infarct Size Reduction.
    Heusch G; Kleinbongard P; Rassaf T
    Circ Res; 2019 Mar; 124(5):679-680. PubMed ID: 30817254
    [No Abstract]   [Full Text] [Related]  

  • 9. Predicting coronary heart disease.
    Epstein FH
    JAMA; 1967 Sep; 201(11):795-800. PubMed ID: 6071891
    [No Abstract]   [Full Text] [Related]  

  • 10. Remote ischaemic pre- and delayed postconditioning - similar degree of cardioprotection but distinct mechanisms.
    Basalay M; Barsukevich V; Mastitskaya S; Mrochek A; Pernow J; Sjöquist PO; Ackland GL; Gourine AV; Gourine A
    Exp Physiol; 2012 Aug; 97(8):908-17. PubMed ID: 22427438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The NHLBI-sponsored Consortium for preclinicAl assESsment of cARdioprotective therapies (CAESAR): a new paradigm for rigorous, accurate, and reproducible evaluation of putative infarct-sparing interventions in mice, rabbits, and pigs.
    Jones SP; Tang XL; Guo Y; Steenbergen C; Lefer DJ; Kukreja RC; Kong M; Li Q; Bhushan S; Zhu X; Du J; Nong Y; Stowers HL; Kondo K; Hunt GN; Goodchild TT; Orr A; Chang CC; Ockaili R; Salloum FN; Bolli R
    Circ Res; 2015 Feb; 116(4):572-86. PubMed ID: 25499773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From the National Heart, Lung, and Blood Institute (NHLBI): EDTA chelation therapy modestly reduces cardiovascular events.
    National Heart, Lung, and Blood Institute
    Ethn Dis; 2013; 23(3):388. PubMed ID: 23914432
    [No Abstract]   [Full Text] [Related]  

  • 13. Coronary microvascular obstruction: the new frontier in cardioprotection.
    Heusch G
    Basic Res Cardiol; 2019 Oct; 114(6):45. PubMed ID: 31617010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Get with the guidelines.
    LaBresh K
    Med Health R I; 2000 Feb; 83(2):60-1. PubMed ID: 10730056
    [No Abstract]   [Full Text] [Related]  

  • 15. Introduction to proceedings of the NHLBI workshop: New Horizons in cardioprotection--a focused issue of journal of cardiovascular pharmacology and therapeutics.
    Kloner RA; Schwartz Longacre L
    J Cardiovasc Pharmacol Ther; 2011; 16(3-4):222. PubMed ID: 21821519
    [No Abstract]   [Full Text] [Related]  

  • 16. Vagus nerve stimulation exerts cardioprotection against myocardial ischemia/reperfusion injury predominantly through its efferent vagal fibers.
    Nuntaphum W; Pongkan W; Wongjaikam S; Thummasorn S; Tanajak P; Khamseekaew J; Intachai K; Chattipakorn SC; Chattipakorn N; Shinlapawittayatorn K
    Basic Res Cardiol; 2018 May; 113(4):22. PubMed ID: 29744667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in incident coronary heart disease: why are the rates falling?
    Luepker RV
    Circulation; 2008 Feb; 117(5):592-3. PubMed ID: 18250277
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardioprotection: The Disconnect Between Bench and Bedside.
    Rossello X; Yellon DM
    Circulation; 2016 Aug; 134(8):574-5. PubMed ID: 27550967
    [No Abstract]   [Full Text] [Related]  

  • 20. Possible role of thromboxane A2 in remote hind limb preconditioning-induced cardioprotection.
    Sharma R; Randhawa PK; Singh N; Jaggi AS
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jan; 389(1):1-9. PubMed ID: 26531833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.